Enterprise Value
71.45M
Cash
35.99M
Avg Qtr Burn
-1.295M
Short % of Float
1.62%
Insider Ownership
7.63%
Institutional Own.
21.35%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
COYA 301 [Low Dose Interleukin-2 (LD IL-2)] Details Alzheimer's disease, Neurodegenerative disease | Phase 2 Data readout | |
COYA 302 Details Frontotemporal dementia | IND Submission | |
COYA 302 Details Amyotrophic lateral sclerosis | IND Submission |